Similar articles

• Dronedarone is superior to placebo the case for optimism.

  Cooper JA. Cooper JA. J Am Coll Cardiol. 2010 Mar 9;55(10):1052; author reply 1052-3. doi: 10.1016/j.jacc.2009.11.045. J Am Coll Cardiol. 2010. PMID: 20202527 No abstract available.
• Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

  Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH; EURIDIS and ADONIS Investigators. Singh BN, et al. N Engl J Med. 2007 Sep 6;357(10):987-99. doi: 10.1056/NEJMoa054686. N Engl J Med. 2007. PMID: 17804843 Clinical Trial.
• Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.

  Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF. Piccini JP, et al. J Am Coll Cardiol. 2009 Sep 15;54(12):1089-95. doi: 10.1016/j.jacc.2009.04.085. J Am Coll Cardiol. 2009. PMID: 19744618 Review.
• Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).

  Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH; ATHENA Investigators. Page RL, et al. Am J Cardiol. 2011 Apr 1;107(7):1019-22. doi: 10.1016/j.amjcard.2010.11.028. Epub 2011 Feb 4. Am J Cardiol. 2011. PMID: 21296333 Clinical Trial.
• Efficacy and safety of dronedarone: a review of randomized trials.

  Christiansen CB, Torp-Pedersen C, Køber L. Christiansen CB, et al. Expert Opin Drug Saf. 2010 Jan;9(1):189-99. doi: 10.1517/14740330903514105. Expert Opin Drug Saf. 2010. PMID: 20001756 Review.